- Home
- OTRK vs APM Comparison
OTRK vs APM Comparison
Compare OTRK & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTRK
- APM
- Stock Information
- Founded
- OTRK 2003
- APM 2010
- Country
- OTRK United States
- APM United Kingdom
- Employees
- OTRK N/A
- APM N/A
- Industry
- OTRK Misc Health and Biotechnology Services
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- OTRK Health Care
- APM Health Care
- Exchange
- OTRK Nasdaq
- APM Nasdaq
- Market Cap
- OTRK 6.1M
- APM 6.1M
- IPO Year
- OTRK N/A
- APM 2018
- Fundamental
- Price
- OTRK $1.53
- APM $1.07
- Analyst Decision
- OTRK Strong Buy
- APM
- Analyst Count
- OTRK 1
- APM 0
- Target Price
- OTRK $45.00
- APM N/A
- AVG Volume (30 Days)
- OTRK 28.3K
- APM 85.4K
- Earning Date
- OTRK 05-20-2025
- APM 06-17-2025
- Dividend Yield
- OTRK N/A
- APM N/A
- EPS Growth
- OTRK N/A
- APM N/A
- EPS
- OTRK N/A
- APM N/A
- Revenue
- OTRK $10,183,000.00
- APM N/A
- Revenue This Year
- OTRK $50.12
- APM N/A
- Revenue Next Year
- OTRK $55.26
- APM N/A
- P/E Ratio
- OTRK N/A
- APM N/A
- Revenue Growth
- OTRK N/A
- APM N/A
- 52 Week Low
- OTRK $1.27
- APM $0.46
- 52 Week High
- OTRK $5.53
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- OTRK 49.62
- APM 58.89
- Support Level
- OTRK $1.43
- APM $0.83
- Resistance Level
- OTRK $1.55
- APM $1.35
- Average True Range (ATR)
- OTRK 0.10
- APM 0.12
- MACD
- OTRK -0.01
- APM 0.02
- Stochastic Oscillator
- OTRK 44.44
- APM 46.97
About OTRK Ontrak Inc.
Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The group provides a value-based behavioral healthcare company that identifies and engages people with unmet health needs using the proprietary Advanced Engagement System to improve clinical outcomes and reduce total cost of care. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.